ChemMatrix: a New resin for solid phase peptide synthesis.
PCAS has created, in agreement with Matrix Innovation, a new entity PCAS BioMatrix Inc. The new company is in charge of the commercialization worldwide of the ChemMatrix resin among all peptide producers and to companies involved in the synthesis of Oligonucleotides and RNA*.
The ChemMatrix resin is a technological tool enabling synthesis on solid support (peptide - oligonucleotides) and purification of complex molecules from biological origin, proteins mainly used for therapeutic purposes.
This resin is issued from the R&D patented by Matrix Innovation, a start-up company based in Quebec area (Canada)
Your Peptide is : Long, Complex, or Hydrophobic,
PCAS FacilityIn 2006, St-Jean Photochemicals Inc. (PCAS Canadian subsidiary) signed an exclusive agreement and industrial exploitation with Matrix Innovation.
Since 2009: St-Jean Photochemicals Inc. (ISO9001 palnt) is now providing to PCAS BioMatrix all the technical support and produces ChemMatrix resin with different linkers and at different scale: from hundred grams to tens of kilogram.
PCAS group is able to follow up your progress to providing you with a ChemMatrix resin: